Back to results
US 2014/0179716 A1Published application
Bicyclic pyrimidone compounds
AssigneeGlaxo Group Limited
InventorsZehong Wan, Kai Long, Xiaomin Zhang, Haihua Yu
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel bicyclic pyrimidone compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.
Claims17
A compound of Formula (I) or a pharmaceutically acceptable salt thereof,
- wherein:
- R is H or C1-C6alkyl,
- R′ is H, halo, or C1-C6alkyl,
- X is —O—, —NH—, —N(C1-C6alkyl)-, —S— or —CH2—,
- n is 0, 1, 2 or 3, when X is —CH2—, n is 1 or 2,
- Ar is phenyl or heteroaryl, either of which is unsubstituted or substituted with one or more groups selected from the group consisting of CN, halo, OH, —NH2, —NHR1, —NR1R2, C1-C6alkyl, C1-C6alkoxy, and C1-C6haloalkyl, and
- Y is absent or —O—Ar′, —NH—Ar′, —N(C1-C6alkyl)-Ar′, or —(CH2)—Ar′,
- wherein Ar′ is phenyl or heteroaryl, either of which is unsubstituted or substituted with one or more groups selected from the group consisting of CN, halo, OH, —NH2, —NHR1, —NR1R2, C1-C6alkyl, C1-C6alkoxy, and C1-C6haloalkyl, and
- each occurrence of R1 and R2 are independently C1-C6 alkyl.
6 more elements
8-9. (canceled)
17-19. (canceled)
Dependencies are inferred from the claim text.